Iris Hinneburg

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
More and more clinical trials for new drugs are designed as non-inferiority trials. In order to assess the validity of these trials, however, a number of peculiarities have to be considered. This applies, e.g., to the exact definition of "non-inferiority" as well as to the data evaluation methods.
  • 1